In pancreatic carcinoma cells BxPC3 and CFPAC-1, Smad4 reexpression also increased constitutive LM-332 expression levels and additionally restored TGFβ induction of LM-332 [19]. The gene discussed is SMAD4; the disease is exocrine pancreatic carcinoma.